1. Home
  2. Analysis
  3. Alkeran
  4. Bone-neoplasm-malignant

Alkeran and Bone neoplasm malignant - a phase IV clinical study of FDA data

Summary:

Bone neoplasm malignant is reported as a side effect among people who take Alkeran (melphalan), especially for people who are female, 60+ old, also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Bone neoplasm malignant when taking Alkeran. It is created by eHealthMe based on reports of 5,418 people who have side effects when taking Alkeran from the FDA, and is updated regularly.

What is Alkeran?

Alkeran has active ingredients of melphalan. eHealthMe is studying from 5,429 Alkeran users. Check the latest studies of Alkeran.

What is Bone neoplasm malignant?

Bone neoplasm malignant (cancer of bone) is found to be associated with 293 drugs and 214 conditions by eHealthMe. Check the latest studies of Bone neoplasm malignant.

On Jul, 27, 2026

5,418 people reported to have side effects when taking Alkeran.
Among them, 13 people (0.24%) have Bone neoplasm malignant.

Could Alkeran cause Bone neoplasm malignant?

Among these 13 people:

What is the gender of people who have Bone neoplasm malignant when taking Alkeran? *

  • female: 69.23 %
  • male: 30.77 %

What is the age of people who have Bone neoplasm malignant when taking Alkeran? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Alkeran? *

  1. Zometa: 13 people, 100.00%
  2. Aspirin: 12 people, 92.31%
  3. Thalidomide: 9 people, 69.23%
  4. Acetaminophen: 9 people, 69.23%
  5. Zithromax: 8 people, 61.54%
  6. Oxycontin: 8 people, 61.54%
  7. Ambien: 8 people, 61.54%
  8. Aredia: 8 people, 61.54%
  9. Colace: 8 people, 61.54%
  10. Ibuprofen: 8 people, 61.54%

What are other side effects people have besides Bone neoplasm malignant? *

  1. Intervertebral Disc Protrusion (spinal disc protrusion): 12 people, 92.31%
  2. Constipation: 12 people, 92.31%
  3. Fatigue (feeling of tiredness): 12 people, 92.31%
  4. Osteopenia (a condition where bone mineral density is lower than normal): 12 people, 92.31%
  5. Enlarged Heart: 12 people, 92.31%
  6. Osteonecrosis Of Jaw (death of bone of jaw): 12 people, 92.31%
  7. Dyspnea (difficult or laboured breathing): 12 people, 92.31%
  8. Pneumonia: 12 people, 92.31%
  9. Herpes Zoster: 12 people, 92.31%
  10. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 12 people, 92.31%

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 5 people, 38.46%
  2. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Alkeran and have Bone neoplasm malignant?

- Check whether Bone neoplasm malignant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alkeran:

Bone neoplasm malignant treatments and more:

How severe was Bone neoplasm malignant and when was it recovered:

Expand to all the drugs that have ingredients of melphalan:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Alkeran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone neoplasm malignant:

Browse all the conditions that are associated with Bone neoplasm malignant:

How the study uses the data?

The study uses data from the FDA. It is based on melphalan (the active ingredients of Alkeran) and Alkeran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.